Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Arformoterol for EIB in Children
NCT00662779Phase 3Withdrawn
- Sponsor
- The University of New Mexico
- Start
- Apr 2008
- Primary completion
- Mar 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of arformoterol in exercise-induced bronchospasm (EIB) (3 arms), sponsored by The University of New Mexico. Primary endpoint: Superior protection against EIB compared to placebo. Planned start Apr 2008; status: withdrawn.
02
Drugs
arformoterol
03
Conditions
exercise-induced bronchospasm (EIB)
Beyond the preview
Go deeper on NCT00662779.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00662779.